Christopher Pierce, EVP and Chief of Business Oper at Prelude Therapeutics Inc (PRLD), sold 6,590 shares at $40.29 ($266K) on 2021-04-29, disclosed to the SEC on 2021-04-30.
Open-market sale of $266k PRLD by EVP and Chief of Business Oper. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.29 | 3,295 | $133K | 50.0% |
| 2 | $40.29 | 3,295 | $133K | 50.0% |
| Total | $40.29 avg | 6,590 | $266K | 100% |
| Filing → |
| PRLD | SELL | 2021-04-09 | $33K | — | Filing → |
| PRLD | BUY | 2020-09-29 | $71K | — | Filing → |